Severe Pustular Drug Eruptions From Amivantamab: A Case Series

    Brad R. Woodie, Laura Xiang, Matan Rothschild, Kory P. Schrom
    Studysummary In this case series, three patients with advanced non-small cell lung cancer experienced severe skin eruptions and scarring alopecia after treatment with amivantamab, highlighting the critical need for prompt recognition and management of these adverse effects to minimize treatment interruptions.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →